Penumbra, Inc. (PEN)
NYSE: PEN · IEX Real-Time Price · USD
175.99
-1.10 (-0.62%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Penumbra Market Cap
Penumbra has a market cap or net worth of $6.82 billion as of July 2, 2024. Its market cap has decreased by -46.62% in one year.
Market Cap
6.82B
Enterprise Value
6.74B
1-Year Change
-46.62%
Ranking
Category
Stock Price
$175.99
Market Cap Chart
Since September 18, 2015, Penumbra's market cap has increased from $1.23B to $6.82B, an increase of 453.62%. That is a compound annual growth rate of 21.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 6.86B | -29.29% |
| Dec 29, 2023 | 9.71B | 14.91% |
| Dec 30, 2022 | 8.45B | -21.29% |
| Dec 31, 2021 | 10.73B | 68.92% |
| Dec 31, 2020 | 6.35B | 10.79% |
| Dec 31, 2019 | 5.74B | 36.03% |
| Dec 31, 2018 | 4.22B | 32.02% |
| Dec 29, 2017 | 3.19B | 58.19% |
| Dec 30, 2016 | 2.02B | 25.52% |
| Dec 31, 2015 | 1.61B | 30.52% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HealthEquity | 7.58B |
| Cerevel Therapeutics Holdings | 7.50B |
| Intra-Cellular Therapies | 7.25B |
| The Ensign Group | 7.07B |
| Elanco Animal Health | 7.00B |
| Ionis Pharmaceuticals | 6.87B |
| Repligen | 6.87B |
| Blueprint Medicines | 6.79B |